军事知识服务平台
局部皮瓣修复在ⅢB期乳腺癌患者术后皮肤缺损中的应用价值
Application of local flap reconstruction for post-operative skin defects in stage ⅢB breast cancer
摘要 目的:探讨局部皮瓣修复ⅢB期乳腺癌患者术后皮肤缺损的应用价值。方法:回顾性分析2018年1月至2023年12月收治的42例ⅢB期乳腺癌患者的资料,其中24例患者行Auchincloss术联合Ⅰ期局部皮瓣修复术(手术组);18例患者新辅助治疗后未行手术治疗(保守治疗组)。记录患者手术时间、术中出血量、住院时间、皮肤缺损修复方式和皮瓣成活情况;观察两组患者3年总体生存率和无局部复发生存率。结果:患者新辅助治疗有效率为80.95%(34/42),其中完全缓解率为7.14%(3/42),部分缓解率为73.81%(31/42);随访时间[ M( Q1, Q3)]为39(24,61)个月,共死亡5例。手术组患者平均手术时间3.1 h(范围2.5~5.1 h),术中平均出血量310.0 ml(范围243.3~392.0 ml),平均住院时间11.2 d(范围9.5~17.1 d)。平均软组织缺损面积为13.5 cm×24.2 cm(范围12.0 cm×15.0 cm~18.0 cm×26.0 cm)。改良式ZipLine粘贴式皮肤牵张器直接缝合2例(8.3%),矩形皮瓣修复6例(25.0%),旋转皮瓣修复9例(37.5%),背阔肌KISS皮瓣修复7例(29.2%)。23例(95.8%)患者皮瓣Ⅰ期愈合;1例(4.2%)患者出现皮瓣缺血,静脉滴注扩血管药物治疗后愈合。手术组与保守治疗组患者3年总生存率分别为91.67%(22/24)和83.33%(15/24),差异无统计学意义(log-rank P=0.321),手术组和保守治疗组3年无局部复发生存率分别为95.83%(23/24)和66.67%(12/18)(log-rank P=0.012)。 结论:ⅢB期乳腺癌新辅助治疗后行Auchincloss术联合Ⅰ期局部皮瓣转移修复巨大皮肤缺损是可行的。
Abstract:
Objective:To evaluate the safety and therapeutic efficacy local flap reconstruction for skin defects following surgery for Stage ⅢB breast cancer.Methods:A retrospective analysis was conducted on 42 patients with Stage ⅢB cancer admitted between January 2018 and December 2023. Among them, 24 patients underwent Auchincloss procedure combined with Stage local flap reconstruction, while 18 patients received neoadjuvant therapy without surgical intervention. Data recorded included operative time, intraoperative blood loss, hospital stay duration, defect reconstruction methods, and flap survival rates. 3-year overall survival rate and local recurrence-free survival rate were observed in both groups.Results:The neoad therapy efficacy rate for both groups was 80.95%(34/42), consisting of a complete response rate of 7.14%(3/42) and a partial response rate of 73.81%(31/42). The follow-up time [ M ( Q1, Q3)] was 39 (24, 61) months, with a of 5 deaths. Average operative time was 3.1 h (range: 2.5-5.1 h), the mean intraoperative blood loss was 310.0 ml (range: 243.3-392.0 ml), and the mean hospital stay was 11.2 d (range 9.5-17.1 d). The average soft tissue defect area was 13.5 cm×24.2 cm (range 12.0 cm×15.0 cm to 18.0 cm×26.0 cm). Reconstruction methods included direct suturing a modified ZipLine adhesive skin stretcher in 2 cases (8.3%), rectangular flap reconstruction in 6 cases (25.0%), rotation flap reconstruction in 9 cases (37.5%), and latissimus dorsi KISS flap reconstruction in 7 cases (29.2%). Flaps healed in Stage Ⅰ in 23 patients (95.8%); 1 patient (4.2%) experienced flap ischemia, which subsequently healed following intravenous vasodilator therapy. The 3-year overall survival rates for patients in the surgical group and the conservative treatment group were 91.67%(22/24) and 83.33%(15/24), respectively, with no statistically significant difference (log-rank P=0.321); the 3-year local recurrence-free survival for the surgical group and the conservative treatment group were 95.83%(23/24) and 66.67%(12/18), respectively (log-rank P=0.012). Conclusion:The Auchincloss procedure combined with Ⅰ local flap transfer for the repair of massive skin defects following neoadjuvant therapy for Stage ⅢB breast cancer is feasible.